Cell line development platform for SMEs to reduce the length and cost of biologic drug development

Project Information

IcoCell

Grant agreement ID: 718711

DOI 10.3030/718711

Project closed

EC signature date 5 April 2016

Start date 1 May 2016

End date 31 August 2018

Funded under

• INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology

Total cost € 1 614 000,00

EU contribution € 1 129 800,00

Coordinated by

ICOSAGEN CELL FACTORY OU
Estonia